578
Views
26
CrossRef citations to date
0
Altmetric
Review

Updates in the field of non-esophageal gastroesophageal reflux disorder

, , , , , , , , , , , ORCID Icon & ORCID Icon show all
Pages 827-838 | Received 30 Jan 2019, Accepted 16 Jul 2019, Published online: 22 Jul 2019

References

  • Vakil N, Van Zanten SV, Kahrilas P, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–1920.
  • Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:1–14.
  • El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63:871–880.
  • Bor S. Consensus report on gastroesophageal reflux disease in Turkey. Turkish J Gastroenterol. 2017;28:1–2.
  • Dent J, El-Serag HB, Wallander M-A, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.
  • Farrokhi F, Vaezi MF. Laryngeal disorders in patients with gastroesophageal reflux disease. Minerva Gastroenterol Dietol. 2007;53:181–187.
  • Farrokhi F, Vaezi M. Extra-esophageal manifestations of gastroesophageal reflux. Oral Dis. 2007;13:349–359.
  • Hom C, Vaezi MF. Extra-esophageal manifestations of gastroesophageal reflux disease: diagnosis and treatment. Drugs. 2013;73:1281–1295.
  • Frye JW, Vaezi MF. Extraesophageal GERD. Gastroenterol Clin North Am. 2008;37:845–858.
  • Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther. 2003;17:1515–1520.
  • Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice. 2002;16:564–579.
  • Merati AL, Ulualp SO, Lim HJ, et al. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2005;114:177–182.
  • Francis DO, Rymer JA, Slaughter JC, et al. High economic burden of caring for patients with suspected extraesophageal reflux. Am J Gastroenterol. 2013;108:905–911.
  • Boeckxstaens G, El-Serag HB, Smout AJPM, et al. Symptomatic reflux disease: the present, the past and the future. Gut. 2014;63:1185–1193.
  • Roman S, Holloway R, Keller J, et al. Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry. Neurogastroenterol Motil. 2017;29:e12920.
  • Scarpellini E, Boecxstaens V, Broers C, et al. Effect of baclofen on gastric acid pocket in subjects with gastroesophageal reflux disease symptoms. Dis Esophagus. 2016;29:1054–1063.
  • Mello M, Gyawali CP. Esophageal manometry in gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:69–87.
  • Gyawali CP, Roman S, Bredenoord AJ, et al. Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group. Neurogastroenterol Motil. 2017;29:e13104.
  • Savarino E, Giacchino M, Savarino V. Dysmotility and reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2013;21:1.
  • Tolone S, de Cassan C, de Bortoli N, et al. Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD. Neurogastroenterol Motil. 2015;27:1175–1182.
  • Tolone S, De Bortoli N, Marabotto E, et al. Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value?. Neurogastroenterol Motil. 2015;27:1423–1431.
  • Tolone S, Savarino E, Zaninotto G, et al. High-resolution manometry is superior to endoscopy and radiology in assessing and grading sliding hiatal hernia: a comparison with surgical in vivo evaluation. United Eur Gastroenterol J. 2018;6:981–989.
  • Vaezi MF, Katzka D, Zerbib F. Extraesophageal symptoms and diseases attributed to GERD: where is the pendulum swinging now? Clin Gastroenterol Hepatol. 2018;16:1018–1029.
  • Sakin YS, Vardar R, Sezgin B, et al. The diagnostic value of 24-hour ambulatory intraesophageal pH-impedance in patients with laryngopharyngeal reflux symptoms comparable with typical symptoms. United Eur Gastroenterol J. 2017;5:632–640.
  • Ribolsi M, Savarino E, De Bortoli N, et al. Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther. 2014;40:966–973.
  • Milstein CF, Charbel S, Hicks DM, et al. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of endoscopic technique (Rigid vs. Flexible Laryngoscope). Laryngoscope. 2005;115:2256–2261.
  • de Bortoli N, Nacci A, Savarino E, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J. Gastroenterol. 2012;18:4363.
  • Zentilin P, Dulbecco P, Savarino E, et al. Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux. Dig Liver Dis. 2004;36:565–569.
  • Savarino E, Zentilin P, Frazzoni M, et al. Characteristics of gastro-esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers. Neurogastroenterol Motil. 2010;22:1061–e280.
  • Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance–pH off therapy. Am J Gastroenterol. 2010;105:1053–1061.
  • Savarino E, Zentilin P, Tutuian R, et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol. 2008;103:2685–2693.
  • Savarino E, Marabotto E, Zentilin P, et al. The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis. 2011;43:542–547.
  • Savarino E, Zentilin P, Marabotto E, et al. Overweight is a risk factor for both erosive and non-erosive reflux disease. Dig Liver Dis. 2011;43:940–945.
  • Savarino E, Zentilin P, Savarino V. NERD: an umbrella term including heterogeneous subpopulations. Nat Rev Gastroenterol Hepatol. 2013;10:371–380.
  • Wei C. A meta-analysis for the role of proton pump inhibitor therapy in patients with laryngopharyngeal reflux. Eur Arch Otorhinolaryngol. 2016;273:3795–3801.
  • Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole. Laryngoscope. 2006;116:254–260.
  • Ren L-H, Chen W-X, Qian L-J, et al. Addition of prokinetics to PPI therapy in gastroesophageal reflux disease: a meta-analysis. World J Gastroenterol. 2014;20:2412.
  • Vaezi MF, Qadeer MA, Lopez R, et al. Laryngeal cancer and gastroesophageal reflux disease: a case-control study. Am J Med. 2006;119:768–776.
  • Labenz J. Facts and fantasies in extra-oesophageal symtoms in GORD. Best Pract Res Clòinical Gastroenterol. 2010;24:893–904.
  • Morice AH. Epidemiology of Cough. Pulm Pharmacol Ther. 2002;15:253–259.
  • Francis DO, Vaezi MF. Should the reflex be reflux? Throat symptoms and alternative explanations. Clin Gastroenterol Hepatol. 2015;13:1560–1566.
  • Kahrilas PJ, Smith JA, Dicpinigaitis PV. A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate. Lung. 2014;192:39–46.
  • Fuchs KH, Babic B, Breithaupt W, et al. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753–1773.
  • Smith JA, Decalmer S, Kelsall A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms. Gastroenterology. 2010;139:754–762.
  • Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328.
  • Everett CF, Morice AH. Clinical history in gastroesophageal cough. Respir Med. 2007;101:345–348.
  • Vaezi MF, Hagaman DDSlaughter JC, et al. Proton pump inhibitor therapy improves symptoms in postnasal drainage. Gastroenterology. 2010 Dec;139(6):1887–1893.e1
  • Pawar S, Lim HJ, Gill M, et al. Treatment of postnasal drip with proton pump inhibitors. a prospective, randomixed, placebo-controlled study. Am J Rhinol. 2007;21:695–701.
  • Kahrilas PJ, Howden CW, Hughes N, et al. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease. Chest. 2013;143:605–612.
  • Kahrilas PJ, Altman KW, Chang AB, et al. Chronic cough due to gastroesophageal reflux in adults: CHEST guideline and expert panel report. Chest. 2016;150:1341–1360.
  • Herregods TVK, Pauwels A, Tack J, et al. Reflux-cough syndrome: assessment of temporal association between reflux episodes and cough bursts. Neurogastroenterol Motil. 2017;29:1–7.
  • Lugaresi M, Aramini B, Daddi N, et al. Effectiveness of antireflux surgery for the cure of chronic cough associated with gastroesophageal reflux disease. World J Surg. 2015;39:208–215.
  • Sandur V, Murugesh M, Banait V, et al. Prevalence of gastro-esophageal reflux disease in patients with difficult to control asthma and effect of proton pump inhibitor therapy on asthma symptoms, reflux symptoms, pulmonary function and requirement for asthma medications. J Postgraduade Med. 2014;60:282–286.
  • Naik RD, Vaezi MF. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay. Expert Rev Gastroenterol Hepatol. 2015;9:969–982.
  • Crowell MD, Zayat EN, Lacy BE, et al. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest. 2001;120(4):1184–1189.
  • Zhu GC, Gao X, Wang ZG, et al. Experimental study for the mechanism of gastroesophageal-reflux-associated asthma. Dis Esophagus. 2014;27:318–324.
  • Hait EJMcDonald DR. Impact of Gastroesophageal Reflux Disease on Mucosal Immunity and Atopic Disorders. Clin Rev Allergy Immunol. 2018 Sep 11. doi:10.1007/s12016-018-8701-4. [Epub ahead of print]
  • Reddy AP, Gupta M. Management of asthma: the current US and European guidelines. Adv Exp Med Biol. 2014;795:81–103.
  • Kahrilas PJ. Gastroesophageal reflux disease. N Engl J Med. 2008;359:1700–1707.
  • Marsicano JA, de Moura-Grec PG, Bonato RCS, et al. Gastroesophageal reflux, dental erosion, and halitosis in epidemiological surveys: a systematic review. Eur J Gastroenterol Hepatol. 2013;25:135–141.
  • Wilder-Smith CH, Materna A, Martig L, et al. Gastro-oesophageal reflux is common in oligosymptomatic patients with dental erosion: a pH-impedance and endoscopic study. United Eur Gastroenterol J. 2015;3:174–181.
  • Wilder-Smith CH, Materna A, Martig L, et al. Longitudinal study of gastroesophageal reflux and erosive tooth wear. BMC Gastroenterol. 2017;17:113.
  • Schlueter N, Luka B. Erosive tooth wear – a review on global prevalence and on its prevalence in risk groups. BDJ. 2018;224:364–370.
  • Muñoz JV, Herreros B, Sanchiz V, et al. Dental and periodontal lesions in patients with gastro-oesophageal reflux disease. Dig Liver Dis. 2003;35:461–467.
  • Roberts MW, Li S-H. Oral findings in anorexia nervosa and bulimia nervosa: a study of 47 cases. J Am Dent Assoc. 1987;115:407–410.
  • Vinesh E, Masthan K, Kumar MS, et al. A clinicopathologic study of oral changes in gastroesophageal reflux disease, gastritis, and ulcerative colitis. J Contemp Dent Pract. 2016;17:943–947.
  • Deppe H, Mücke T, Wagenpfeil S, et al. Erosive esophageal reflux vs. non erosive esophageal reflux: oral findings in 71 patients. BMC Oral Health. 2015;15:84.
  • Moshkowitz M, Horowitz N, Leshno M, et al. Halitosis and gastroesophageal reflux disease: a possible association. Oral Dis. 2007;13:581–585.
  • Lee H-J, Kim HM, Kim N, et al. Association between halitosis diagnosed by a questionnaire and halimeter and symptoms of gastroesophageal reflux disease. J Neurogastroenterol Motil. 2014;20:483–490.
  • Kislig K, Wilder-Smith CH, Bornstein MM, et al. Halitosis and tongue coating in patients with erosive gastroesophageal reflux disease versus nonerosive gastroesophageal reflux disease. Clin Oral Investig. 2013;17:159–165.
  • Wang J, Yu Z, Ren J, et al. Effects of pepsin A on heat shock protein 70 response in laryngopharyngeal reflux patients with chronic rhinosinusitis. Acta Otolaryngol. 2017;137:1253–1259.
  • Southwood JE, Hoekzema CR, Samuels TL, et al. The impact of pepsin on human nasal epithelial cells in vitro. Ann Otol Rhinol Laryngol. 2015;124:957–964.
  • Leason SR, Barham HP, Oakley G, et al. Association of gastro-oesophageal reflux and chronic rhinosinusitis: systematic review and meta-analysis. Rhinol J. 2017;55:3–16.
  • Lin Y-H, Chang T-S, Yao Y-C, et al. Increased risk of chronic sinusitis in adults with gastroesophgeal reflux disease. Medicine (Baltimore). 2015;94:e1642.
  • Bakshi SS. Chronic rhinosinusitis in gastroesophageal reflux disease. Am J Rhinol Allergy. 2015;29:e225–e225.
  • Schiöler L, Ruth M, Jõgi R, et al. Nocturnal GERD - a risk factor for rhinitis/rhinosinusitis: the RHINE study. Allergy. 2015;70:697–702.
  • Katle EJ, Hatlebakk JG, Grimstad T, et al. Gastro-oesophageal reflux in patients with chronic rhinosinusitis investigated with multichannel impedance - pH monitoring. Rhinol J. 2017;55:27–33.
  • DiBaise JK, Olusola BF, Huerter JV, et al. Role of GERD in chronic resistant sinusitis: a prospective, open label, pilot trial. Am J Gastroenterol. 2002;97:843–850.
  • Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. Longo DL, editor. N Engl J Med. 2018;378:1811–1823.
  • Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136–142.
  • Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:1390–1394.
  • Savarino E, Carbone R, Marabotto E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013;42:1322–1331.
  • Savarino E, Bazzica M, Zentilin P, et al. Gastroesophageal reflux and pulmonary fibrosis in scleroderma. Am J Respir Crit Care Med. 2009;179:408–413.
  • Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med. 2013;1:369–376.
  • Bédard Méthot D, Leblanc É, Lacasse Y. Meta-analysis of gastroesophageal reflux disease and idiopathic pulmonary fibrosis. Chest. 2019;155:33–43.
  • Raghu G, Rochwerg B, Zhang Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192:e3–e19.
  • Raghu G, Pellegrini CA, Yow E, et al. Laparoscopic anti-reflux surgery for the treatment of idiopathic pulmonary fibrosis (WRAP-IPF): a multicentre, randomised, controlled phase 2 trial. Lancet Respir Med. 2018;6:707–714.
  • Kreuter M, Wuyts W, Renzoni E, et al. Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis. Lancet Respir Med. 2016;4:381–389.
  • Fidler L, Sitzer N, Shapera S, et al. Treatment of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Chest. 2018;153:1405–1415.
  • Tasker A, Dettmar PW, Panetti M, et al. Reflux of gastric juice and glue ear in children. Lancet. 2002;359:493.
  • Poelmans J, Tack J, Feenstra L. Prospective study on the incidence of chronic ear complaints related to gastroesophageal reflux and on the outcome of antireflux therapy. Ann Otol Rhinol Laryngol. 2002;111:933–938.
  • Górecka-Tuteja A, Jastrzębska I, Składzień J, et al. Laryngopharyngeal reflux in children with chronic otitis media with effusion. J Neurogastroenterol Motil. 2016;22:452–458.
  • Miura MS, Mascaro M, Rosenfeld RM. Association between otitis media and gastroesophageal reflux. Otolaryngol Neck Surg. 2012;146:345–352.
  • Schreiber S, Garten D, Sudhoff H. Pathophysiological mechanisms of extraesophageal reflux in otolaryngeal disorders. Eur Arch Oto-Rhino-Laryngology. 2009;266:17–24.
  • Basoglu OK, Vardar R, Tasbakan MS, et al. Obstructive sleep apnea syndrome and gastroesophageal reflux disease: the importance of obesity and gender. Sleep Breath. 2015;19:585–592.
  • Oh JH. Gastroesophageal reflux disease: recent advances and its association with sleep. Ann N Y Acad Sci. 2016;1380:195–203.
  • Savarino E, Bredenoord AJ, Fox M, et al. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017;14:665–676.
  • Roman S, Gyawali CP, Savarino E, et al. Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: update of the Porto consensus and recommendations from an international consensus group. Neurogastroenterol Motil. 2017;29:1–15.
  • Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018;67:1351–1362.
  • Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut. 2015;64:373–380.
  • Yadlapati R, Adkins C, Jaiyeola D-M, et al. Abilities of oropharyngeal pH tests and salivary pepsin analysis to discriminate between asymptomatic volunteers and subjects with symptoms of laryngeal irritation. Clin Gastroenterol Hepatol. 2016;14:535–542.e2.
  • Sontag SJ, O’Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux. Long term results of a randomized trial of medical and surgical antireflux therapies. Am J Gastroenterol. 2003;98:987–999.
  • Frazzoni L, Frazzoni M, de Bortoli N, et al. Postreflux swallow-induced peristaltic wave index and nocturnal baseline impedance can link PPI-responsive heartburn to reflux better than acid exposure time. Neurogastroenterol Motil. 2017;29:e13116.
  • Frazzoni M, de Bortoli N, Frazzoni L, et al. Impairment of chemical clearance and mucosal integrity distinguishes hypersensitive esophagus from functional heartburn. J Gastroenterol. 2017;52:444–451.
  • Frazzoni M, Savarino E, de Bortoli N, et al. Analyses of the post-reflux swallow-induced peristaltic wave index and nocturnal baseline impedance parameters increase the diagnostic yield of impedance-pH monitoring of patients with reflux disease. Clin Gastroenterol Hepatol. 2016;14:40–46.
  • de Bortoli N, Martinucci I, Savarino E, et al. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn. Clin Gastroenterol Hepatol. 2015;13:1082–1088.e1.
  • Frazzoni M, Frazzoni L, Tolone S, et al. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn. Am J Gastroenterol. 2018;113:670–676.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.